^
    NTRK1 fusion
    Spindle Cell Sarcoma
    entrectinib
    Sensitive: C1 - Off-label
    NTRK3 fusion
    Spindle Cell Sarcoma
    entrectinib
    Sensitive: C1 - Off-label
    KRAS G12V
    Spindle Cell Sarcoma
    BAL3833
    Sensitive: C3 – Early Trials
    SMARCB1 negative
    Spindle Cell Sarcoma
    tazemetostat
    Sensitive: C3 – Early Trials
    TPM3-NTRK1 fusion
    Spindle Cell Sarcoma
    larotrectinib
    Sensitive: C4 – Case Studies
    KIAA1549-BRAF fusion + PTEN deletion
    Spindle Cell Sarcoma
    bevacizumab + sorafenib + temsirolimus
    Sensitive: C4 – Case Studies